Summary
Johnson & Johnson (JNJ) filed a Form 8-K on April 15, 2003, to report its consolidated financial results for the first quarter ended March 30, 2003. This filing primarily serves to furnish a press release and supplementary sales data, as required by Regulation FD. Investors should note that this report does not contain extensive new operational details but rather disseminates previously announced financial performance metrics. The key takeaway for investors from this 8-K is the official announcement and availability of JNJ's first-quarter 2003 sales and earnings. While the filing itself is procedural, the attached press release (Exhibit 99.15) and supplementary data (Exhibit 99.20) are the crucial documents for understanding the company's recent financial performance, including sales trends and earnings per share for the period.
Key Highlights
- 1Filing of Form 8-K on April 15, 2003, reporting on the period ended March 30, 2003.
- 2Announcement of consolidated financial results for the first quarter of 2003.
- 3Furnished a press release dated April 15, 2003, detailing Q1 2003 sales and earnings.
- 4Included Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings as an exhibit.
- 5The filing adheres to Regulation FD disclosure requirements.
- 6Stephen J. Cosgrove, Chief Accounting Officer, signed the report.